Amanda Glassman
Executive Vice President of CGD, CEO of CGD Europe, and Senior Fellow
Topics:
Governments and Development, Corruption, Transparency, and Governance, Gender and Equality, Latin America Initiative, Development Impact Bonds, Population and Development Research Agenda, Global Health, Achieving More Health for the Money, iDSI and Priority-Setting, Health Benefits Packages, Better Fiscal Policy for Health, Evaluating Health Programs, Millions Saved, Family Planning, Global Health Innovation and Access: Sustainable Business Models, The Future of Global Health Procurement, Vaccines, Global Health Security, Coronavirus Preparedness & Response, Antimicrobial Resistance, Global Health Policy Research Network
Expertise
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Bio
Amanda Glassman is executive vice president and senior fellow at the Center for Global Development and also serves as chief executive officer of CGD Europe. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books What's In, What's Out: Designing Benefits for Universal Health Coverage (Center for Global Development, 2017), Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
Media Contact
Sean Bartlett
sbartlett@cgdev.org
Featured Work
In the News
Working Groups
High-res photo
More From Amanda Glassman
October 28, 2013
Blog Post
The Economist’s take on the Give Directly evaluation argues that unconditional cash transfers (UCT) “don’t deal with the deeper causes of poverty.” The article cites Baird and co-authors’ review showing that vigorously enforced conditional cash transfer (CCT) programs generate larger effects on school enrollment than UCT, and suggests that CCT are thus better positioned to address the root causes of poverty.
October 25, 2013
Publication
The Global Fund is currently finalizing design and implementation of its New Funding Model (NFM), which includes a focus on strengthened measurement and an impact-based investment strategy.
October 23, 2013
Publication
This is the data set for Policy Paper 33 in which Victoria Fan, Denizhan Duran, Rachel Silverman, and Amanda Glassman
October 23, 2013
Publication
More than ever, global health funding agencies must get better value for money from their investment portfolios; to do so, each agency must know the interventions it supports and the sub-populations targeted by those interventions in each country. In this study we examine the interventions supported by two major international AIDS funders: the Global Fund to Fight AIDS, Tuberculosis, and Malaria (‘Global Fund’) and the President’s Emergency Plan for AIDS Relief (PEPFAR).
October 22, 2013
Blog Post
It appears that the worst kept secret in Washington is out: Ambassador Goosby is expected to step down as Global AIDS Coordinator later this year. As CGD has done for similar leadership transitions, we are working on a report to examine the future direction of PEPFAR and consider which tasks PEPFAR’s next leader should put near the top of the program’s list of priorities. One preliminary conclusion: Goosby’s successor will certainly face programmatic challenges, but the political ones may prove to be more difficult.
October 16, 2013
Blog Post
It seems the more people hear about behavioral economics, the more misconceptions seem to pop up. So today we&r
October 2, 2013
Blog Post
Argentina is a highly decentralized federal country, where more than 70% of public spending on health happens sub-nationally by independent provincial governments. Since budgetary transfers between levels of government have no conditions attached, the federal government has often struggled to influence the efficiency and impact of provincial government spending.
Pages
June 13, 2013
Blog Post
This is a joint post with Jenny Ottenhoff.
April 15, 2019
Featured from CGD
Background research and resources from CGD's growing porfolio on the future of global health procurement.
December 13, 2010
Blog Post
This weekend, children in Nicaragua received Advance Market Commitment (AMC)-financed pneumococcal vaccines that prot
October 25, 2013
Publication
The Global Fund is currently finalizing design and implementation of its New Funding Model (NFM), which includes a focus on strengthened measurement and an impact-based investment strategy.
August 1, 2012
Blog Post
Economists are not global health’s most popular human resource.
September 8, 2011
Blog Post
December 17, 2012
Blog Post
Ambassador Eric Goosby has been selected to head the US Department of State’s new Office of Global Health Diplomacy, officially turning the page in the ongoing saga of the program formally known as the Global Health Initiative (GHI). Goosby’s appointment will be on top of his role as US global AIDS coordinator, through which he oversees the President’s Emergency Plan for AIDS Relief (PEPFAR), and former Ambassador Leslie Rowe will be in charge of the office’s daily operations. But while the long-awaited announcement said the new office will provide “diplomatic support in implementing the Global Health Initiative’s principles and goals,” it stirred many of the same questions and concerns that arose from the GHI death notice and left me wondering: is this news a Christmas miracle or a lump of coal for US global health programs?
February 2, 2011
Blog Post
Bill Gates’ effort to close the $2.6 billion funding gap for polio eradication has been accompanied by high-profile c
Commentary Menu